新闻

Gabriella Muscolo honored, along with Luca Arnaudo AGCM, during Concurrences Antitrust Writing Awards

Washington DC, 28 March 2023

Franzosi Dal Negro Setti appoints Franco Guariglia equity partner

The role of the Court experts in patent litigation in Italy and before UPC

Our Agata Sobol comments an interesting ruling by the Court of Cassation on Court experts and thier role now and with the entrance of the UPC - EIRP 45 - January 2023

Are alternative resolution instruments effective mechanism in the health and medical sector?

Starting from the recent judicial reform on ADRs by Legislative Decree 149/2022, and after gaining an expertise in the both areas of judicial and pharmaceutical law, our Chiara Brighenti analyses their functioning and current applicability.

We wish you a wonderful Christmas and a 2023 full of satisfaction and joy.

An overview on the Italian Pharma & Medical Device regulation

Lexology GTDT - Italy - October 2022

An overview of the Italian National Health Service: key features and future challenges

Stefano Giberti and Erica Benigni provide a description of the current state of the NHS and the developments of digital health in the chapter dedicated to Italy in the prestigious "The Healthcare Law Reviews" edition 6

Once again, awarded as Law Firm of the Year, by ABL, Alliance of Business Lawyers

Chicago, September 2022

Patent settlements in the pharmaceutical sector

Our Gabriella Muscolo author, with Luca Arnaudo, Italian Competition Authority (AGCM) and Italian Medicines Agency (AIFA), of an article on the hot topic issued by Concurrences last 1st September 2022.

Stefano Giberti and Erica Benigni contributors for Chambers Medical Devices & Consumer Health Products 2022 Global Practice Guide

An overview of Italian regulations on medical devices, drugs and other products such as biocides and cosmetics, with particular reference to new technologies.